Shareholders and Investors

Oryzon Genomics, S.A. has created this section for its shareholders and investors as proof of its commitment to transparency. This section includes all of the information required under the applicable legislation in this connection, as well as the information deemed relevant for investors.

Investor Contacts

Please contact us for investor information.

Contact Us

  • Phone: (+34) 93 707 4100


Investor Events & Presentations

11-21 June, 2020
25th Congress of the European Hematology Association, EHA-2020
Location: entirely virtual meeting
e-Poster presentation: Friday, June 12th 2020   at 8:30 CEST
Title: “Iadademstat Shows Efficacy in Combination with Azacitidine in Elderly AML Patients. ALICE Trial”
Lugar: Location: